ALK and mesenchymal cell neoplasm: Ensartinib in a primary pulmonary &lt;i&gt;ALK&lt;/i&gt;-rearranged mesenchymal neoplasm harboring a novel &lt;i&gt;HMBOX1::ALK&lt;/i&gt; fusion: a case report and literature review.